Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (60)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Regression Models and Life-Tables
1992 • 27,454 citations
Regression Models and Life-Tables
1972 • 27,145 citations
Statistical Methods for Rates and Proportions
2003 • 17,930 citations
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 • 8,468 citations
Nonparametric Estimation from Incomplete Observations
1958 • 7,673 citations
Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>
1976 • 5,620 citations
Statistical Methods for Rates and Proportions, 2nd ed
1981 • 3,735 citations
Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
1985 • 2,981 citations
Bone marrow transplant
1999 • 2,452 citations
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
1964 • 763 citations
Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)
1985 • 752 citations
Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults
1968 • 559 citations
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]
1990 • 525 citations
Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia
1995 • 458 citations
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B
1981 • 451 citations
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]
1990 • 446 citations
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B
1981 • 395 citations
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
1985 • 366 citations
PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL
1986 • 329 citations
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study
1987 • 305 citations
Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
1983 • 279 citations
Varying intensity of postremission therapy in acute myeloid leukemia
1992 • 272 citations
Cytarabine and neurologic toxicity.
1991 • 264 citations
Varying intensity of postremission therapy in acute myeloid leukemia
1992 • 228 citations
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.
1989 • 149 citations
Failure of remission induction in acute myelocytic leukemia
1978 • 148 citations
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
1991 • 135 citations
ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVAL
1984 • 119 citations
A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial
1984 • 108 citations
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia
1992 • 99 citations
Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
1987 • 95 citations
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
1992 • 93 citations
Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.
1987 • 91 citations
High dose cytarabine: a review.
1988 • 77 citations
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.
1992 • 76 citations
T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission
1992 • 73 citations
Acute nonlymphoblastic leukemia. Prognostic factors in adults with long-term follow-up
1982 • 72 citations
T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission
1992 • 72 citations
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
1987 • 69 citations
Distribution of 250 Cases of Acute Myeloid Leukaemia (AML) according to the FAB Classification and Response to Therapy
1981 • 62 citations
The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia.
1982 • 58 citations
Long-term disease-free survival in acute nonlymphocytic leukemia
1981 • 56 citations
Long term survival in acute myeloid leukemia: The eastern cooperative oncology group (ECOG) experience
1991 • 53 citations
Progress report from the International Bone Marrow Transplant Registry.
1992 • 53 citations
The heritable nature of clonal characteristics in acute myeloblastic leukemia
1981 • 52 citations
Reasons That Patients with Acute Myelogenous Leukemia Do Not Undergo Allogeneic Bone Marrow Transplantation
1992 • 50 citations
CHEMOTHERAPY VERSUS TRANSPLANTATION IN ACUTE LEUKAEMIA
1989 • 46 citations
1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.
1993 • 42 citations
The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia
1987 • 42 citations
Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? [editorial; comment]
1992 • 42 citations
Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
1991 • 39 citations
Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a "best choice"?
1988 • 38 citations
Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria
1982 • 35 citations
The Approach to the Elderly Patient with Acute Myeloid Leukemia
1993 • 34 citations
ACUTE MYELOID LEUKAEMIA: IS ‘CONSOLIDATION’THERAPY NECESSARY?
1984 • 16 citations
Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia
1986 • 15 citations
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B
1993 • 14 citations
In adult acute nonlymphoblastic leukaemia extended maintenance chemotherapy has no benefit
1984 • 14 citations
Short‐term remission induction and consolidation therapy for adult acute myelogenous leukemia
1991 • 8 citations
Cited By (0)
No citing papers found in database